Angiotensin Receptor and Neprilysin Inhibitors for COVID-19 Treatment and Personalized Medicine?
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Omics : a journal of integrative biology - 26(2022), 5 vom: 01. Mai, Seite 318-319 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kow, Chia Siang [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Comment |
|---|
| Anmerkungen: |
Date Completed 17.05.2022 Date Revised 07.12.2022 published: Print-Electronic CommentOn: OMICS. 2021 Jul;25(7):408-416. - PMID 34191617 Citation Status MEDLINE |
|---|
| doi: |
10.1089/omi.2022.0030 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM340118903 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM340118903 | ||
| 003 | DE-627 | ||
| 005 | 20231226004424.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1089/omi.2022.0030 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1133.xml |
| 035 | |a (DE-627)NLM340118903 | ||
| 035 | |a (NLM)35483040 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kow, Chia Siang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Angiotensin Receptor and Neprilysin Inhibitors for COVID-19 Treatment and Personalized Medicine? |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.05.2022 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: OMICS. 2021 Jul;25(7):408-416. - PMID 34191617 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Proto-Oncogene Mas |2 NLM | |
| 650 | 7 | |a Receptors, Angiotensin |2 NLM | |
| 650 | 7 | |a Neprilysin |2 NLM | |
| 650 | 7 | |a EC 3.4.24.11 |2 NLM | |
| 700 | 1 | |a Ramachandram, Dinesh Sangarran |e verfasserin |4 aut | |
| 700 | 1 | |a Hasan, Syed Shahzad |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Omics : a journal of integrative biology |d 2002 |g 26(2022), 5 vom: 01. Mai, Seite 318-319 |w (DE-627)NLM117661910 |x 1557-8100 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2022 |g number:5 |g day:01 |g month:05 |g pages:318-319 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1089/omi.2022.0030 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2022 |e 5 |b 01 |c 05 |h 318-319 | ||